DONATE
FOR PHYSICIANS
HEALTH AND NUTRITION
ETHICAL RESEARCH & EDUCATION
MEDIA CENTER
LEGISLATIVE FOCUS
CLINICAL RESEARCH
EDUCATIONAL LITERATURE
MEMBERSHIP
SHOP

Connect with Us

 

 

The Physicians Committee



2014 PCRM Year End Matching Gift


BREAKING MEDICAL NEWS April 9, 2008

Inhaled Insulin Product Linked to Lung Cancer

April 9, 2008

Exubera, an inhaled insulin delivery system, has been linked to an increased risk of lung cancer. Pfizer released this statement today:

"Over the course of the clinical trial program, 6 of the 4,740 Exubera-treated patients versus 1 of the 4,292 patients not treated with Exubera developed lung cancer. In addition there was a post-marketing report of lung cancer in one Exubera-treated patient."

All affected patients had a prior smoking history. It is not yet clear whether Exubera aggravates cancer risk in smokers and former smokers or the link is simply coincidental. The company is updating product labeling to reflect the findings.

On October 18, 2007, Pfizer announced its plan to discontinue the product after disappointing sales.

Subscribe to the Physicians Committee's Breaking Medical News.

Breaking Medical News is a service of the Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., Ste. 400, Washington, DC 20016, 202-686-2210. Join the Physicians Committee and receive the quarterly magazine, Good Medicine.



   
This site does not provide medical or legal advice. This Web site is for informational purposes only.
Full Disclaimer | Privacy Policy

The Physicians Committee
5100 Wisconsin Ave., N.W., Ste.400, Washington DC, 20016
Phone: 202-686-2210     Email: pcrm@pcrm.org